Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports

Background When a new drug becomes available, patients and doctors require information on its benefits and harms. In 2011, Germany introduced the early benefit assessment of new drugs through the act on the reform of the market for medicinal products (AMNOG). At market entry, the pharmaceutical comp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ
Main Authors: Köhler, Michael, Haag, Susanne, Biester, Katharina, Brockhaus, Anne Catharina, McGauran, Natalie, Grouven, Ulrich, Kölsch, Heike, Seay, Ulrike, Hörn, Helmut, Moritz, Gregor, Staeck, Kerstin, Wieseler, Beate
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group Ltd. 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4353284/
https://ncbi.nlm.nih.gov/pubmed/25722024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.h796
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados